Eli Lilly Commits $500 Million to Strengthen South Korea as a Global Longevity and Biotech Hub
April 2, 2026
No Comments
Global pharmaceutical leader Eli Lilly and Company today announced a $500 million investment over the next five years to advance South Korea’s pharmaceutical and biotechnology